MIAO HELP Complementary food in powder form for cats, which helps protect the urinary tract. Indicated as a complementary remedy for cystitis and other urinary tract infections, it is particularly effective against Escherichia coli, Klebsiella, Enterococcus faecalis, Streptococcus, Staphylococcus, Proteus, Pseudomonas and other fimbriated bacteria. Unlike antibiotic therapy, the bacteria are not destroyed, but mechanically eliminated, washed away with the urinary stream. This prevents the deterioration of the physiological bacterial flora, a valuable ally of the animals health. AUSILIUM MIAO can be administered in cases of recurrent and recurrent cystitis, both in the acute phases and as a preventive measure. ingredients Maltodextrin, pork liver meal, D-Mannose. Botanically defined natural products: Morinda citrifolia L. extract 70,000 mg. How to use Mix the powder into the regular wet food ration according to the following daily dose: - up to 10 kg of weight: 2 teaspoons per day, in two doses, for a total of 3 g; - over 10 kg in weight: 4 teaspoons per day, in two doses, for a total of 6 g. For prevention and maintenance, half the dose will be sufficient. If exclusively dry food is fed, moisten the food slightly to allow the powder to adhere well and ensure complete absorption. It is recommended to carry out a 10-15 day administration cycle, which can be repeated if necessary, at the discretion of the veterinarian. warnings For veterinary use only. Keep out of reach of children. Conservation Store in a dry place, away from light. Format 100g package. Code PT267 Bibliography : 1. Abgottspon D, Rabbani S, Herold J, Jiang X, Ernst B. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation . Klein J Med Chem Dec 2010;53:8627-41. 2. Akihisa T, Matsumoto K, Tokuda H. Anti-inflammatory and potentially cancer chemopreventive constituents from Morinda citrifolia (Noni) fruits . J Nat Prod 2007;70:754-7. 3. Alitheen NB, Manaf AA, Yeap SK. Immunomodulatory effects of damnacanthal isolated from the roots of Morinda elliptica . Pharm Biol 2010;48:446-52. 4. Altarac S, Papes D. The use of d-mannose in the prophylaxis of recurrent urinary tract infections (UTI) in women . BJU Int 2014;113:9-10. 5. American Chemical Society. Noni Plant May Produce New Drugs to Fight Tuberculosis . Press Releases at the 2000 Pacific Basin International Chemical Society Congress. 6. Crepin S, Houle S, Carbanneau ME, Mourez M, Harel J, Dozois CM. Reduced expression of type 1 fibromas by a pst mutant of uropathogenic Escherichia urinary tract infection: contribution to intracellular biofilm development . Virulence 2010;1:333-7. 7. Cusumano CK, Pinkner JS, Han Z, Handerson JP, Croweley JR, Hultgren SJ. Treatment and prevention of urinary tract infections with orally active FimH inhibitors . Sci Transl Med Nov 2011;3:109-15. 8. Gupta RK, Banerjee A, Pathak S. Induction of mitochondrial-mediated apoptosis by Morinda citrifolia (Noni) in human cervical cancer cells . Asian Pac J Cancer Prev 2013;14:237-42. 9. Gupta RK, Patel AK. Are the health claims made for Morinda citrifolia (Noni) consistent with current scientific knowledge and evaluation of its biological effects ? Asian Pac J Canc Prev 2013;14:147-49. 10. Heinicke R. The xeronine system: a novel cellular mechanism explaining the health-promoting action of NONI and Bromeliads . Direct Source Pub 2001. 11. Jiang X, Abgottspon D, Kleeb S, Rabbani S, Scharenberg M, Wittwer M et al. Antiadhesion therapy for urinary tract infections - a balanced pharmacokinetic/pharmacodynamic profile has been shown to be essential for success . J Med Chem 2012;55:4700-13. 12. Kranjcec B, Papes D, Altarac S. D-mannose powder for the prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial . World J Urol 2013;32:79-84. 13. Nava CM, Ricciardo G, Valieri M. Treatment and prevention of vaginitis recurrence . Medicinae Doctor 2013 issue 8. 14. Pawlus AD, On BN, Keller WJ. An anthraquinone with potent quinone reductase-inducing activity and other constituents of Morinda citrifolia (Noni) fruit . J Nat Prod 2005;68:1720-2. 15. Porru D, Parmigiani A, Tinelli C, Barletta D, Choussos D, Di Franco C, Bobbi V, Bassi S, Miller O, Gardella B, Nappi RE, Spinillo A and Rovereto B. Oral D-mannose in recurrent urinary tract infections in women: A pilot study . J Clin Urol 2014;20(10)1–6. 16. Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagellar motility, chemotaxis, and type 1 pili. Mol Microbiol 1998;30:285-93. 17. Reid G, Sobel JD. Bacterial adherence in the pathogenesis of urinary tract infections: a review . Clin Infect Dis 1987;9:470-87. 18. Sharon N. Carbohydrates as future antiadherent drugs for infectious diseases . Biochim Biophys Acta 2006;1760:527-37. 19. Umezawa K. Isolation of 1-methoxy-2-formyl3-hydroxyanthraquinone from M. citrifolia and the neoplasm inhibitors containing it . Japan Kokai Tokyo Koho JP 1992;87:736(94-87, 736). 20. Wellens A, Garofalo C, Nguyen H, Van Gerven N, Bouckaert J. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-ologomannose-3 complex . PLoS one 2008;3:e2040